Intel Reveals European Expansion & Pilot Plans for Intel Health Guide

IntelIntel (NASDAQ: INTC) announced at the World Congress for Information Technology that it will be expanding availability of the Intel® Health Guide in Europe and is working with strategic industry partners in France, Germany, Spain and The Netherlands to bring localised versions of the Intel Health Guide to market over the coming year.

The Intel Health Guide, a regulated device that carries the CE mark under the EU Medical Device Directive, combines an in-home patient device, the Intel Health Guide PHS6000, with the Intel Health Care Management Suite, an online interface that allows clinicians to securely monitor patients in their homes and manage care remotely. It was designed to help address the challenges of chronic conditions for patients, their family caregivers and the healthcare professionals responsible for their care.

"Chronic conditions can account for 70 percent of total health expenditure in Europe, especially if the conditions are poorly managed. With the average age of the population in Europe increasing, the number of people with chronic conditions will increase substantially over the coming years," said Doug Busch, Vice President and Chief Technical Officer of Intel's Digital Health Group. "The announcement today represents a major step forward in addressing new models of care. It demonstrates an industry commitment to developing the personal health market globally, with the goal of utilising technology to improve the lives of seniors and people living with chronic illness."

Addressing the challenges of an ageing population is a goal shared by the European Commission, which recently adopted its European Action Plan - Ageing Well in the Information Society. The plan highlights the key role of information and communication technologies in providing older people with a better quality of life and in reducing costs for both health and social care. Between now and 2013, the EU and its member states will invest more than €1 billion in research and innovation in these technologies.

Intel's commitment to addressing the global challenges of an ageing population
The Intel Health Guide is already commercially available in the United Kingdom, United States, Ireland and Australia. In The Netherlands, the localised language Intel Health Guide is now available and Fujitsu is the first market reseller to sell the Intel Health Guide. In addition, Intel is working with the Martini Hospital and CurIT in Groningen to conduct a pilot project using the Intel Health Guide, funded through local and European subsidies. In this project, the Intel Health Guide is used for pregnant women with diabetes.

Intel is also continuing to work with other leading market channel partners to bring the Intel Health Guide to market globally, and additional localised European language versions of the Intel Health Guide will be announced later this year.

  • In France, Intel recently announced its collaboration with Orange Healthcare and plans to cooperate on a telehealth pilot project with the Moulins-Yzeure Hospital in the Auvergne region of France to support care of chronic obstructive pulmonary disease (COPD) patients post-discharge using the Intel Health Guide.
  • In Germany, the Asklepios Hospital Group - one of Europe's largest private Hospital Groups - recently announced a new eHealth-Services strategy and partner model to provide innovative eHealth mobile, online and home health services and solutions. Asklepios and Intel will cooperate on a joint telehealth pilot project to support care of Asklepios patients post-discharge using the Intel Health Guide.
  • In Spain, Telefonica is working with Intel on a pilot project and plans to announce first findings later this year.
  • In the United Kingdom, BT is the latest market partner selling the Intel Health Guide. GE Healthcare and Intel recently announced a sales and marketing agreement for the Intel Health Guide in the United Kingdom. GE Healthcare already markets the Intel Health Guide in the United States.

A comprehensive personal health system
The Intel Health Guide allows clinicians to monitor patients in their homes and manage care remotely via a secure server. It was designed to help address the challenges of chronic conditions for patients, their family, carers and the health care professionals responsible for their care. The system offers interactive tools for personalised care management and includes vital signs collection, patient reminders, surveys, multimedia educational content, and feedback and communications tools such as video conferencing and email notifications. It can connect to specific models of wired and wireless medical devices, including blood pressure monitors, glucose meters, pulse oximeters, peak flow meters and weight scales.

Using a secure server, health care professionals can remotely review and act on this information. As a result, clinicians have ongoing access to data so that they can better manage each patient’s conditions. Patients benefit from customised care in the comfort of their home and can also monitor their health status and communicate with care teams.

The localised versions of the Intel Health Guide are Continua-compliant, signalling Intel's commitment to standardisation and interoperability. The Continua-compliant English language version will be released later this year. In June 2006, Intel and other founding member companies announced the formation of the Continua Health Alliance. Today, the Alliance has over 200 members from business and representative organisations. This open industry group seeks to ensure that health technologies are compatible, meet common standards and work seamlessly together. The main focus of the Alliance is on creating guidelines for industry across three major categories: chronic disease management, monitoring the health and healthcare needs of ageing people and proactive health and fitness.

Related news articles:

About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at www.intel.com/pressroom and blogs.intel.com.

For more information on the Intel Health Guide, visit www.intel.com/healthcare/telehealth. To learn more about Intel in healthcare, go to www.intel.com/healthcare.

Intel is a trademark of Intel Corporation or its subsidiaries in the United States and other countries.

Other names and brands may be claimed as the property of others

The Intel Health Guide requires an internet connection to enable communications with the patient's care team and back-end data hosting. The Intel Health Guide is intended for use by patients under the guidance of a healthcare professional and is not intended for emergency medical communications or real-time patients monitoring.

The Intel Health Guide is designed to be used by health care professionals to manage their patients at home and is not currently available for general consumer purchase.

Most Popular Now

New Computational Model of Real Neurons …

Nearly all the neural networks that power modern artificial intelligence (AI) tools such as ChatGPT are based on a 1960s-era computational model of a living neuron. A new model developed...

Meet CARMEN, a Robot that Helps People w…

Meet CARMEN, short for Cognitively Assistive Robot for Motivation and Neurorehabilitation - a small, tabletop robot designed to help people with mild cognitive impairment (MCI) learn skills to improve memory...

AI Matches Protein Interaction Partners

Proteins are the building blocks of life, involved in virtually every biological process. Understanding how proteins interact with each other is crucial for deciphering the complexities of cellular functions, and...

Mobile Phone Data Helps Track Pathogen S…

A new way to map the spread and evolution of pathogens, and their responses to vaccines and antibiotics, will provide key insights to help predict and prevent future outbreaks. The...

AI Model to Improve Patient Response to …

A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU). DeepPT, developed...

Can AI Tell you if You Have Osteoporosis…

Osteoporosis is so difficult to detect in early stage it’s called the "silent disease." What if artificial intelligence could help predict a patient’s chances of having the bone-loss disease before...

Study Reveals Why AI Models that Analyze…

Artificial intelligence (AI) models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that these models don’t always...

Think You're Funny? ChatGPT might b…

A study comparing jokes by people versus those told by ChatGPT shows that humans need to work on their material. The research team behind the study published on Wednesday, July 3...

Innovative, Highly Accurate AI Model can…

If there is one medical exam that everyone in the world has taken, it's a chest x-ray. Clinicians can use radiographs to tell if someone has tuberculosis, lung cancer, or...

New AI Approach Optimizes Antibody Drugs

Proteins have evolved to excel at everything from contracting muscles to digesting food to recognizing viruses. To engineer better proteins, including antibodies, scientists often iteratively mutate the amino acids -...

AI Speeds Up Heart Scans, Saving Doctors…

Researchers have developed a groundbreaking method for analysing heart MRI scans with the help of artificial intelligence (AI), which could save valuable NHS time and resources, as well as improve...

Young People Believe that AI is a Valuab…

Children and young people are generally positive about artificial intelligence (AI) and think it should be used in modern healthcare, finds the first-of-its-kind survey led by UCL and Great Ormond...